UBS O'Connor’s Healthcare Services Acquisition Corporation Warrant HCARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-78,453
Closed -$27K – 1065
2022
Q1
$27K Buy
78,453
+1,388
+2% +$596 ﹤0.01% 932
2021
Q4
$40K Buy
77,065
+2,067
+3% +$1.32K ﹤0.01% 919
2021
Q3
$47K Hold
74,998
– – ﹤0.01% 892
2021
Q2
$69K Hold
74,998
– – ﹤0.01% 852
2021
Q1
$47K Buy
+74,998
New +$92.2K ﹤0.01% 794

Other funds holding HCARW

UBS O'Connor's HCARW Position: Q2 2022 in Review

UBS O'Connor sold out of Healthcare Services Acquisition Corporation Warrant (HCARW) in Q2 2022, closing a stake of 78,453 shares — an estimated $27K sold.

UBS O'Connor first reported a position in HCARW in Q1 2021 and held it in 5 quarters. The position peaked at $69K in Q2 2021. 46 funds tracked by Wall St. Rank hold HCARW as of Q2 2022.

  • UBS O'Connor reported no remaining Healthcare Services Acquisition Corporation Warrant position as of Q2 2022 after selling out during the quarter.
  • UBS O'Connor sold 78,453 Healthcare Services Acquisition Corporation Warrant shares in Q2 2022, an estimated $27K.
  • UBS O'Connor first reported a position in Healthcare Services Acquisition Corporation Warrant in Q1 2021 and held it in 5 quarters.
  • UBS O'Connor's Healthcare Services Acquisition Corporation Warrant position peaked at $69K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Warrant as of Q2 2022.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.